• Product nameAnti-TORC2 antibody
    See all TORC2 primary antibodies
  • Description
    Mouse monoclonal to TORC2
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment: QDPHTFNHQN LTHCSRHGSG PNIILTGDSS PGFSKEIAAA LAGVPGFEVS AAGLELGLGL EDELRMEPLG LEGLNMLSDP CALLPDPAVE ESFRSDRLQ, corresponding to amino acids 595-693 of human Torc2 (NP_859066) with a proprietary tag.

  • Positive control
    • HeLa cell lysate; the immunogen


Associated products


Our Abpromise guarantee covers the use of ab89179 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 - 5 µg/ml. Predicted molecular weight: 73 kDa.
ELISA Use at an assay dependent dilution.


  • FunctionTranscriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR).
  • Tissue specificityMost abundantly expressed in the thymus. Present in both B and T lymphocytes. Highly expressed in HEK293T cells and in insulinomas. High levels also in spleen, ovary, muscle and lung, with highest levels in muscle. Lower levels found in brain, colon, heart, kidney, prostate, small intestine and stomach. Weak expression in liver and pancreas.
  • Sequence similaritiesBelongs to the TORC family.
  • Post-translational
    Phosphorylation/dephosphorylation states of Ser-171 are required for regulating transduction of CREB activity. TORCs are inactive when phosphorylated, and active when dephosphorylated at this site. This primary site of phosphorylation, is regulated by cAMP and calcium levels and is dependent on the phosphorylation of SIKs by LKB1. Both insulin and AMPK increase this phosphorylation, of TORC2 while glucagon suppresses it.
  • Cellular localizationCytoplasm. Nucleus. Translocated from the nucleus to the cytoplasm on interaction of the phosphorylated form with 14-3-3 protein. In response to cAMP levels and glucagon, relocated to the nucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • CREB regulated transcription coactivator 2 antibody
    • CREB-regulated transcription coactivator 2 antibody
    • CRTC2 antibody
    • CRTC2_HUMAN antibody
    • RP11-422P24.6 antibody
    • TORC-2 antibody
    • torc2 antibody
    • Transducer of CREB protein 2 antibody
    • Transducer of regulated cAMP response element-binding protein antibody
    • Transducer of regulated cAMP response element-binding protein (CREB) 2 antibody
    • Transducer of regulated cAMP response element-binding protein 2 antibody
    • Transducer of regulated CREB protein 2 antibody
    see all

Anti-TORC2 antibody images

References for Anti-TORC2 antibody (ab89179)

ab89179 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab89179.
Please use the links above to contact us or submit feedback about this product.